Inherited factor XI deficiency: A concise review

Hematology

Volumn 11, Issue 5-6, 2006, Pages 307-309

  Franchini, Massimo ^a   Veneri, Dino ^b   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11 CONCENTRATE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOPLASTIN; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL FEATURE; GENETIC ANALYSIS; HUMAN; INHERITANCE; MONOTHERAPY; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SUBSTITUTION THERAPY;

BLOOD COAGULATION DISORDERS, INHERITED; DISEASE MANAGEMENT; FACTOR XI DEFICIENCY; HEMORRHAGE; HUMANS;

EID: 34250747928     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600921964     Document Type: Review

References (23)

1. Smith, JK (1996) Factor XI deficiency and its management. Haemophilia, 2, pp. 128-136.
2. Bolton-Maggs, PHB (1995) Factor XI deficiency: A review. Haemophilia, 1, pp. 217-221.
3. Bolton-Maggs, PHB, Perry, DJ and Chalmers, EA (2004) The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia, 10, pp. 593-628.
4. Salomon, O. and Seligsohn, U. (2004) New observations on factor XI deficiency. Haemophilia, 10, pp. 184-187.
5. Broze Jr, GJ and Gailani, D. (1993) The role of factor XI in coagulation. Thromb Haemost, 70, pp. 72-74.
6. Borne, PAK Von dem, Meijers, JC and Bouma, BN (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood, 86, pp. 3035-3042.
7. Hancock, JF, Wieland, K. and Pugh, RE (1991) A molecular genetic study of factor XI deficiency. Blood, 77, pp. 1942-1948.
8. Zivelin, A., Bauduer, F. and Ducout, L. (2002) Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood, 99, pp. 2448-2454.
9. Bolton-Maggs, PHB, Peretz, H. and Butler, R. (2004) A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost, 2, pp. 918-924.
10. Zadra, G., Asselta, R. and Malcovati, M. (2004) Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica, 89, pp. 1332-1340.
11. Kravtsov, D. and Meijers, JC (2004) Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood, 104, pp. 128-134.
12. Asakai, R., Chung, DW, Davie, EW and Seligsohn, U. (1991) Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med, 3253, pp. 153-158.
13. Kadir, RA, Economides, DL and Lee, CA (1999) Factor XI deficiency in women. Am J Hematol, 60, pp. 48-54.
14. Bolton-Maggs, PHB (1998) The managment of factor XI deficiency. Haemophilia, 4, pp. 683-688.
15. Bolton-Maggs, PH, Colvin, BT, Satchi, BT, Lee, CA and Lucas, GS (1994) Thrombogenic potential of factor XI concentrate. Lancet, 344, pp. 748-749.
16. Mannucci, PM, Bauer, KA and Santagostino, E. (1994) Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood, 84, pp. 1314-1319.
17. Berliner, S., Horowitz, I., Martinowitz, U., Brenner, B. and Seligsohn, U. (1992) Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis, 3, pp. 465-468.
18. Cattaneo, M. (1997) Review of clinical experience of desmopressin in patients with congenital and acquired bleeeding disorders. Eur J Anaesthesiol, 14, pp. 10-18.
19. Castaman, G., Ruggeri, M. and Rodeghiero, F. (1996) Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency. Br J Hematol, 94, pp. 168-170.
20. Bauduer, F., Bendriss, P., Freyburger, G., Ducout, L. and Marti, B. (1998) Use of desmopressin for prophylaxis of surgical bleeding in factor XI-deficient patients. Acta Haematol, 99, pp. 52-53.
21. Franchini, M., de Gironcoli, M., Lippi, G., Manzato, F., Aprili, G. and Gandini, G. (2000) Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. Haematologica, 85, pp. 106-107.
22. Salomon, O., Zivelin, A. and Livnat, T. (2003) Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood, 101, pp. 4783-4788.
23. Lawler, P., White, B. and Pye, S. (2002) Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia, 8, pp. 145-148.